Form 4: CVS Director Jeffrey Balser Acquires Shares

CVS Health Director Jeffrey R. Balser acquired 2,058 shares of common stock as part of a semi-annual retainer payment.

Summary

• Director Jeffrey R. Balser acquired 2,058 shares of CVS Health common stock on May 14, 2026.
• The shares were issued at a price of $97.15 per share.
• The transaction was part of a semi-annual retainer payment under the 2017 Incentive Compensation Plan.
• Following this transaction, the director's total beneficial ownership is 15,717 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director compensation.

Positives

• Director demonstrates alignment with shareholder interests through the acquisition of company equity.

Negatives

• None.

Risks

• None.

Future Outlook

Not applicable as this is a routine disclosure of director compensation.

Industry Context

StockSavvy.ai notes that director equity acquisitions via retainer plans are standard corporate governance practices intended to align board member incentives with long-term shareholder value.

Comparison to Industry Standards

• The issuance of equity as part of director compensation is consistent with standard practices among S&P 500 healthcare companies.
• The transaction follows standard SEC reporting requirements for Section 16 insiders.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard compensation-related equity issuance.

Next Steps

• None.

Key Dates

Keywords

CVS, Insider Trading, Form 4, Director Compensation, Equity Ownership